Establishment of protective immunity against cerebral cryptococcosis by means of an avirulent, non melanogenic Cryptococcus neoformans strain

Journal of Neuroimmunology

Volumn 109, Issue 2, 2000, Pages 75-86

  Barluzzi, Roberta ^a   Brozzetti, Annalisa ^a   Mariucci, Giuseppina ^b   Tantucci, Michela ^b   Neglia, Rachele G ^c   Bistoni, Francesco ^a   Blasi, Elisabetta ^c  

^a Microbiology Section   (Italy)

^b Dept Exp Med Biochem Sci U   (Italy)

^c Department of Hygiene   (Italy)

Author keywords

Cerebral cryptococcosis; Cryptococcus neoformans; Protective immunity

Indexed keywords

CATECHOLAMINE DERIVATIVE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 1BETA; MELANIN; NITRIC OXIDE SYNTHASE; PROTEIN P40; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFECTION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNITY; IMMUNOMODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE INJURY; VIRULENCE;

ANIMAL; ASTROCYTES; BRAIN DISEASES; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FEMALE; GENE EXPRESSION; GLIAL FIBRILLARY ACIDIC PROTEIN; HYPERSENSITIVITY, DELAYED; INTERLEUKIN-1; INTERLEUKIN-12; LECTINS; MELANINS; MICE; MICE, INBRED C57BL; MICROGLIA; SUPPORT, NON-U.S. GOV'T; TUMOR NECROSIS FACTOR; VIRULENCE;

EID: 0034703309     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(00)00319-2     Document Type: Article

References (43)

1. Aguirre K., Havell E.A., Gibson G.W., Johnson L.L. Role of tumor necrosis factor and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice. Infect. Immun. 63:1995;1725-1731.
2. Alspaugh J.A., Granger D.L. Inhibition of Cryptococcus neoformans replication by nitrogen-oxides supports the role of these molecules as effectors of macrophages-mediated cytostasis. Infect. Immun. 59:1991;2291-2296.
3. Barluzzi R., Brozzetti A., Delfino D., Bistoni F., Blasi E. Role of capsule in microglial cell-Cryptococcus neoformans interaction: impairment of antifungal activity but not secretory functions. Med. Mycol. 36:1998;189-197.
4. Barluzzi R., Mazzolla R., Brozzetti A., Puliti M., Mariucci G., Mosci P., Bistoni F., Blasi E. A low virulent strain of Candida albicans enhances brain anticryptococcal defenses: characterization of the local immune reaction by RT-PCR and histochemical analysis. J. Neuroimmunol. 79:1997;37-48.
5. Blasi E., Barluzzi R., Bocchini V., Mazzolla R., Bistoni F. Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. J. Neuroimmunol. 27:1990;229-237.
6. Blasi E., Barluzzi R., Mazzolla R., Bistoni F. Differential host susceptibility to intracerebral infection with Candida albicans and Cryptococcus neoformans. Infect. Immun. 61:1993;3476-3481.
7. Blasi E., Barluzzi R., Mazzolla R., Mosci P., Bistoni F. Experimental model of intracerebral infection with Cryptococcus neoformans: role of phagocytes and opsonization. Infect. Immun. 60:1992;3682-3688.
8. Blasi E., Barluzzi R., Mazzolla R., Pitzurra L., Puliti M., Saleppico S., Bistoni F. Biomolecular events involved in anticryptococcal resistance in the brain. Infect. Immun. 63:1995;1218-1222.
9. Blasi E., Barluzzi R., Mazzolla R., Tancini B., Saleppico S., Puliti M., Pitzurra L., Bistoni F. Role of nitric oxide and melanogenesis in the accomplishment of anticryptococcal activity by the BV-2 microglial cell line. J. Neuroimmunol. 58:1995;111-116.
10. Blasi E., Mazzolla R., Barluzzi R., Mosci P., Bistoni F. Anticryptococcal resistance in the mouse brain: beneficial effects of local administration of heat-inactivated yeast cells. Infect. Immun. 62:1994;3189-3196.
11. Chao C.C., Hu S., Molitor T.W., Shaskan E.G., Peterson P.K. Activated microglia mediate neuronal injury via a nitric oxide mechanism. J. Immunol. 149:1992;2736-2741.
12. Chaskes S., Tindall R. Pigment production by Cryptococcus neoformans from para- and orto-diphenols: effect of the nitrogen source. J. Clin. Microbiol. 1:1975;509-514.
13. Chen G.H., Curtis J.L., Mody C.H., Cristensen P.I., Armstrong L.R., Toews G.B. Effect of granulocyte-macrophage colony-stimulating factor on rat alveolar macrophages anticryptococcal activity in vitro. J. Immunol. 152:1994;725-734.
14. Chomczynski P., Sacchi N. Single-step method of RNA isolation by guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
15. Clemons K.V., Brummer E., Stevens D.A. Cytokine treatment of central nervous system infection: efficaci of interleukin-12 alone and synergy with conventional antifungal therapy in experimental cryptococcosis. Antimicrob. Agents Chemother. 38:1994;460-464.
16. Collins H.L., Bancroff G.J. Cytokine enhancement of complement dependent phagocytosis by macrophages: synergy of TNFα and GMCSF for Cryptococcus neoformans. Eur. J. Immunol. 22:1992;1447-1454.
17. Cunha A., Jefferson J.A., Jackson R.W., Vitrovic L. Glial cell-specific mechanisms of TGF-β induction by IL-1 in cerebral cortex. J. Neuroimmunol. 42:1993;71-86.
18. Fabry Z., Raine C.S., Hart M.N. Nervous tissue as an immune compartment: the dialect of the immune response in the CNS. Immunol. Today. 15:1994;218-224.
19. Fierz W., Endler B., Reske K., Wekerle H., Fontana A. Astrocytes as antigen-presenting cells. Induction of Ia antigen on astrocytes by T cells via immune interferon and its effect on antigen presentation. J. Immunol. 134:1995;3785-3790.
20. Frei K., Sielp C., Groscurth P., Schwerdel C., Fontana A. Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells. Eur. J. Immunol. 17:1987;1271-1278.
21. Giulian D. Ameboid microglia as effectors in inflammation in the central nervous system. J. Neurosci. Res. 18:1987;155-171.
22. Huffnale G.B., Chen G.H., Curtis J.L., McDonald R.A., Strieter R.M., Toews G.B. Down regulation of the afferent phase of T-cell-mediated pulmonary inflammation and immunity by a high melanin-producing strain of Cryptococcus neoformans. J. Immunol. 155:1995;3507-3516.
23. + T cells. J. Exp. Med. 173:1991;793-800.
24. Jacobson E.S., Tinnell S.B. Antioxidant function of fungal melanin. J. Bacteriol. 175:1993;7102-7104.
25. Kawakami K., Tohyama M., Teruya K., Kudeken N., Xie Q., Saito A. Contribution of interferon-γ in protecting mice during pulmonary and disseminated infection with Cryptococcus neoformans. FEMS Immunol. Med. Microbiol. 13:1996;123-130.
26. Kawakami K., Xie Q., Tohyama M., Qureshi M.H., Saito A. Contribution of tumor necrosis factor-alpha (TNFα) in host defence mechanism against Cryptococcus neoformans. Clin. Exp. Immunol. 106:1996;468-474.
27. Kawakami K., Tohyama M., Xie Q., Saito A. IL-12 protects mice against pulmonary and disseminated infection caused by Cryptococcus neoformans. Clin. Exp. Immunol. 104:1996;208-214.
28. Kawakami K., Tohyama M., Xie Q., Saito A. Expression of cytokines and inducible nitric oxide synthase mRNA in the lung of mice infected with Cryptococcus neoformans: effects of interleukin-12. Infect. Immun. 65:1997;1307-1312.
29. Kossmann M.C.M., Kossmann T.K., Wahl S. Cytokines and neuropathology. Trends Pharmacol. Sci. 13:1992;286-291.
30. Lee S.C., Dickson D.W., Brosnan C.F., Casadevall A. Human astrocytes inhibit Cryptococcus neoformans growth by a nitric oxide-mediated mechanism. J. Exp. Med. 180:1994;365-369.
31. Mazzolla R., Barluzzi R., Romani L., Mosci P., Bistoni F. Anti-Candida resistance in the mouse brain and effect of intracerebral administration of interleukin-1. J. Gen. Microbiol. 137:1991;1799-1804.
32. Mitchell T.G., Perfect J.R. Cryptococcosis in the era of AIDS - 100 years after the discovery of Cryptococcus neoformans. Clin. Microbiol. Rev. 8:1995;515-548.
33. Nosanchuk J.D., Rosas A.L., Casadevall A. The antibody response to fungal melanin in mice. J. Immunol. 160:1998;6026-6031.
34. Nosanchuk J.D., Valadon P., Feldmesser M., Casadevall A. Melanization of Cryptococcus neoformans in murine infection. Mol. Cell. Biol. 19:1999;745-750.
35. Polak A. Melanin as a virulence factor in pathogenic fungi (Review). Mycoses. 33:1989;215-224.
36. Rhodes J.C., Polacheck I., Kwon-Chung K.J. Phenoloxidase activity and virulence in isogenic strains of Cryptococcus neoformans. Infect. Immun. 36:1982;1175-1184.
37. Shrikant P., Benviste E.N. The central nervous system as an immunocompetent organ. Role of glial cells in antigen presentation. J. Immunol. 157:1996;1819-1822.
38. Tran E.H., Hardin-Pouzet H., Verge G., Owens T. Astrocytes and microglia express inducible nitric oxide synthase in mice with experimental allergic encephalomyelitis. J. Neuroimmunol. 74:1997;121-129.
39. Trinchieri G. Interleukin-12 a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:1995;251-276.
40. Wang Y., Casadevall A. Susceptibility of melanized and non melanized Cryptococcus neoformans to nitrogen and oxygen-derived oxidants. Infect. Immun. 64:1994;3004-3007.
41. Wang Y., Casadevall A. Growth of Cryptococcus neoformans in presence of L-dopa decreases its susceptibility to amphotericin B. Antimicrob. Agents Chemother. 38:1994;2648-2650.
42. Wang Y., Aisen P., Casadevall A. Cryptococcus neoformans melanin and virulence: mechanism of action. Infect. Immun. 63:1995;3131-3136.
43. Yoshida A., Koide Y., Uchijeama M., Yoshida T.O. Dissection of strain difference in acquired protective immunity against Mycobacterium bovis Calmette-Guerin (BCG). J. Immunol. 155:1995;2057-2066.